Skip to main content
Bertrand Liang, MD, Neurology, Colorado Springs, CO, Highland Hospital

BertrandLiangMDPhD, MBA/AMP, PgDipl, FAAN

Neurology Colorado Springs, CO

Hospital/Neurohospitalist, Neurooncology

Managing Director, LCC Ventures

Dr. Liang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Liang's full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemResidency, Neurology, 1989 - 1992
  • Brown University
    Brown UniversityInternship, Internal Medicine, 1988 - 1989
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1988
  • University of Bolton
    University of BoltonPhD, Molecular Biology
  • MIT Sloan School of Management
    MIT Sloan School of Management AMP/MGMT, Management
  • University College London
    University College LondonPgDipl, Law
  • UCSD PRR
    UCSD PRRPrimary Care, Primary Care

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - 2025
  • CO State Medical License
    CO State Medical License 1995 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • MI State Medical License
    MI State Medical License 1990 - 2024
  • GA State Medical License
    GA State Medical License 2023 - 2024
  • KS State Medical License
    KS State Medical License 2023 - 2024
  • OK State Medical License
    OK State Medical License 2021 - 2023
  • American Board of Psychiatry and Neurology Neurology
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Sporadic Adult-Onset Brainstem Hyperkalemic Periodic Paralysis Masquerading as Recurrent Transient Ischemic Attacks.  
    Liang KMA, and BC Liang, Clinical Case Reports
  • Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared with Daily Filgrastim after Chemotherapy for Lymphoma  
    . JM Vose, Crump M, Lazarus H, Emmanouilides C, Schenkein D, Moore J, Frankel S, Flinn I, Lovelace W, Hackett J, Liang BC, Journal of Clinical Oncology, 2003
  • Pegfilgrastim: Optimized Management of Chemotherapy-induced Neutropenia with a Single Fixed Dose  
    . J Crawford, Holmes FA, Green M and Liang BC, Cancer Investigation, 2003
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Other

Authored Content

  • Dr. Bertrand’s Patient Stories11/23/2018

Press Mentions

  • Purple Biotech Announces Initiation of Phase 1b/2 Clinical Trial of CM24 for Treatment of Multiple Advanced Cancers
    Purple Biotech Announces Initiation of Phase 1b/2 Clinical Trial of CM24 for Treatment of Multiple Advanced CancersMarch 19th, 2021
  • Kitov Expands Planned Phase 1/2 Clinical Trial of CM24 in Non-Small Cell Lung Cancer with New Cohort to Evaluate CM24 in Patients with Pancreatic Cancer Conducted with Bristol Myers Squibb
    Kitov Expands Planned Phase 1/2 Clinical Trial of CM24 in Non-Small Cell Lung Cancer with New Cohort to Evaluate CM24 in Patients with Pancreatic Cancer Conducted with Bristol Myers SquibbNovember 9th, 2020
  • Kitov Pharma Announces Appointment of Bertrand Liang, M.D., Ph.D., as Chief Medical Officer
    Kitov Pharma Announces Appointment of Bertrand Liang, M.D., Ph.D., as Chief Medical OfficerJanuary 9th, 2020

Professional Memberships

Hospital Affiliations